Traws Pharma, Inc. Increase (Decrease) in Other Operating Liabilities
Traws Pharma, Inc. (TRAW) reported Increase (Decrease) in Other Operating Liabilities of -$1.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2016-11-14
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for the quarter ending 2015-09-30 was $0.00.
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for the quarter ending 2015-06-30 was $0.00.
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for the quarter ending 2015-03-31 was -$1.00K.
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for the quarter ending 2014-12-31 was $0.00.
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for fiscal 2014 was -$5.00K.
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for fiscal 2013 was -$37.00K.
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for fiscal 2012 was -$41.00K, a 170.69% decline from fiscal 2011.
- Traws Pharma, Inc. increase (decrease) in other operating liabilities for fiscal 2011 was $58.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | -$1.00K 10-Q · filed 2016-11-14 | -$1.00K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$1.00K 10-Q · filed 2016-08-15 | -$1.00K derived: sum of 3 quarters · filed 2016-08-15 | -$2.00K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$1.00K 10-Q · filed 2016-05-11 | -$1.00K derived: sum of 2 quarters · filed 2016-05-11 | -$2.00K derived: sum of 3 quarters · filed 2016-05-11 | -$3.00K derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$1.00K derived: sum of 2 quarters · filed 2015-11-12 | -$2.00K derived: sum of 3 quarters · filed 2015-11-12 | -$5.00K 10-K · filed 2015-03-30 |
| 2014-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$2.00K derived: sum of 2 quarters · filed 2015-11-12 | -$5.00K 10-Q · filed 2015-11-12 | -$28.00K derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$4.00K 10-Q · filed 2015-08-13 | -$27.00K derived: sum of 3 quarters · filed 2015-08-13 | -$44.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | -$3.00K 10-Q · filed 2015-05-15 | -$26.00K derived: sum of 2 quarters · filed 2015-05-15 | -$43.00K derived: sum of 3 quarters · filed 2015-05-15 | -$60.00K derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$40.00K derived: sum of 2 quarters · filed 2015-03-30 | -$57.00K derived: sum of 3 quarters · filed 2015-03-30 | -$37.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$34.00K derived: sum of 2 quarters · filed 2014-11-14 | -$14.00K 10-Q · filed 2014-11-14 | -$24.00K derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $3.00K 10-Q · filed 2014-08-14 | -$7.00K derived: sum of 3 quarters · filed 2015-03-30 | -$18.00K derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | $20.00K 10-Q · filed 2014-05-15 | $10.00K derived: sum of 2 quarters · filed 2015-03-30 | -$1.00K derived: sum of 3 quarters · filed 2015-03-30 | |
| 2012-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$21.00K derived: sum of 2 quarters · filed 2015-03-30 | -$41.00K 10-K · filed 2015-03-30 | |
| 2012-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$31.00K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | -$20.00K 10-Q · filed 2013-09-06 | |||
| 2011-12-31 | $58.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |